You are here

January 2018

MHA Statement on the Institute for Clinical and Economic Review’s Final Report on Tardive Dyskinesia

Mental Health America (MHA) congratulates the Institute for Clinical and Economic Review (ICER) on the release of its final report, Vesicular Monoamine Transporter 2 Inhibitors for Tardive Dyskinesia: Effectiveness and Value, and thanks ICER for engaging MHA throughout the process.

MHA Statement on Revisions to 42 CFR Pt II

Mental Health America (MHA) applauds the Substance Abuse and Mental Health Services Administration (SAMHSA) for updating and considering further revisions to the patient confidentiality rule 42 CFR Pt II in its January 3, 2018 final rule.

500 Montgomery Street, Suite 820
 Alexandria, VA 22314

Phone (703) 684.7722

Toll Free (800) 969.6642

Fax (703) 684.5968


Web Sponsor

Text Resize

-A +A

The links on this page may contain document data that requires additional software to open: